Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reverse transcriptase and protease inhibitors mutational viral load in HIV infected pregnant women with transmitted drug resistance in Argentina.
Cecchini D, Sfalcin J, Zapiola I, Gómez A, Fernández Giuliano S, Mammana L, Seravalle A, Rodríguez C, Fay F, Bouzas MB. Cecchini D, et al. Among authors: zapiola i. Rev Esp Quimioter. 2021 Aug;34(4):371-375. doi: 10.37201/req/022.2021. Epub 2021 Jun 4. Rev Esp Quimioter. 2021. PMID: 34085506 Free PMC article.
Rilpivirine resistance associated mutations in HIV-1 infected pregnant women.
Cecchini DM, Zapiola I, Rodriguez CG, Bouzas MB. Cecchini DM, et al. Among authors: zapiola i. Enferm Infecc Microbiol Clin. 2015 Aug-Sep;33(7):498-9. doi: 10.1016/j.eimc.2014.12.005. Epub 2015 Jan 29. Enferm Infecc Microbiol Clin. 2015. PMID: 25639908 No abstract available.
Etravirine resistance mutations in HIV-infected pregnant women.
Cecchini DM, Zapiola I, Fernandez Giuliano S, Martinez MG, Rodriguez CG, Bouzas MB. Cecchini DM, et al. Among authors: zapiola i. HIV Med. 2013 Feb;14(2):125-6. doi: 10.1111/j.1468-1293.2012.01058.x. HIV Med. 2013. PMID: 23281821 Free article. No abstract available.
Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15.
Bissio E, Barbás MG, Bouzas MB, Cudolá A, Salomón H, Espínola L, Fernández Giuliano S, Kademián S, Mammana L, Ornani ML, Ravasi G, Vila M, Zapiola I, Falistocco C. Bissio E, et al. Among authors: zapiola i. J Antimicrob Chemother. 2017 Feb;72(2):504-510. doi: 10.1093/jac/dkw445. Epub 2016 Oct 26. J Antimicrob Chemother. 2017. PMID: 27789684
Pretreatment HIV-1 Resistance in Argentina: Results from the Second Surveillance Study Following World Health Organization Guidelines (2019).
Laufer NL, Bouzas MB, Fernández Giuliano S, Zapiola I, Mammana L, Salomon H, Monzani C, Castro G, Suarez Ornani ML, Rojas Machado P, Cochon N, Adazsko A, Ravasi G, Vila M, Maulen S, Ceriotto M, Barbas MG, Martini S. Laufer NL, et al. Among authors: zapiola i. AIDS Res Hum Retroviruses. 2024 Aug;40(8):464-470. doi: 10.1089/AID.2023.0083. Epub 2024 Apr 3. AIDS Res Hum Retroviruses. 2024. PMID: 38386507
Update on primary HIV-1 resistance in Argentina: emergence of mutations conferring high-level resistance to nonnucleoside reverse transcriptase inhibitors in drug-naive patients.
Petroni A, Deluchi G, Pryluka D, Rotryng F, Bortolozzi R, Lopardo G, Bouzas MB, Zapiola I, Garone D, Rodríguez C, Chiocconi E, Lázaro ME, Murano F, Maranzana A, Oliva SM, Aparicio M, Beltrán M, Benetucci JA. Petroni A, et al. Among authors: zapiola i. J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):506-10. doi: 10.1097/01.qai.0000222285.44460.e2. J Acquir Immune Defic Syndr. 2006. PMID: 16773027
27 results